Robert R. Ruffolo

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Madison, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Marc Panoff, Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert R. Ruffolo

Form 4 holding Director

Aridis Pharmaceuticals, Inc.

Security class
Restricted Stock Units
Shares / value
10,000
Estimated value
Report date
05 Dec 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Sigilon Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
11 Aug 2023
Price
$0.7500
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Robert R. Ruffolo

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .